23andMe Holding Co.
NASDAQ:ME
23andMe Holding Co.
NASDAQ:ME
Price:
0.5023 USD
-0.46%
Market Closed
Updated:
May 4, 2024
23andMe Holding Co.
Revenue
|
23andMe Holding Co.
Revenue Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
23andMe Holding Co.
NASDAQ:ME
|
Revenue
$299.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$360.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
23andMe Holding Co.
Revenue Breakdown
Breakdown by Geography
23andMe Holding Co.
23andMe Holding Co.
Not Available
Breakdown by Segments
23andMe Holding Co.
23andMe Holding Co.
|
Total Revenue:
299.5m
USD
|
|
Consumer Services:
247.1m
USD
|
|
K I T S:
27.7m
USD
|
See Also
What is 23andMe Holding Co.'s Revenue?
Revenue
299.5m
USD
299.5m
USD
Based on the financial report for Mar 31, 2023, 23andMe Holding Co.'s Revenue amounts to 299.5m USD.
What is 23andMe Holding Co.'s Revenue growth rate?
Revenue CAGR 3Y
-1%
-1%
Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for 23andMe Holding Co. have been -1% over the past three years .
You don't have any saved screeners yet
